Research News and Research

RSS

Study finds different DNA alterations in tumor genomes of smokers and never-smokers

Lung tumors in those who smoke and those who never smoked have different DNA alterations in the tumor genomes, according to results of a pilot study presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.

10 Nov 2010

Study finds no association between working in wafer fabrication cleanrooms, cancer mortality

An exhaustive, five-year epidemiological study conducted by researchers from Vanderbilt University covering more than 100,000 semiconductor industry workers found no association between overall cancer mortality and working in wafer fabrication cleanrooms, the Semiconductor Industry Association reported today.

10 Nov 2010

Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral

Covidien, a leading global provider of healthcare products, announced the results of an analysis that will be presented at the American College of Rheumatology's Annual Scientific Meeting. A pooled analysis of safety data suggests that patients with knee osteoarthritis (OA) receiving the topical PENNSAID® (diclofenac sodium topical solution) 1.5% w/w had significantly fewer gastrointestinal (GI)-related adverse events than those receiving an oral non-steroidal anti-inflammatory drug (NSAID).

10 Nov 2010

Data from AVEO's tivozanib-FOLFOX6 combination Phase 1b trial presented at 22nd EORTC-NCI-AACR

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, will be presented during the 22nd Annual Symposium of EORTC-NCI-AACR being held November 16-19, 2010 in Berlin, Germany.

10 Nov 2010

EuroNanoMed funds 8 projects with €8 Million for transnational research projects in nanomedicine

EuroNanoMed, a European funding initiative under the ERA-Net scheme of the European Commission aimed at advancing transnational research in Nanomedicine, announced today the projects that will be funded following its 2nd joint transnational call for collaborative research projects. Eight projects, involving 46 partners from 10 countries will be funded with €8 Million provided by EuroNanoMed partners. The research projects were chosen from 33 applications involving 178 applicant groups from 19 EU member and associated states/regions.

10 Nov 2010

Conference of The MacLean Center for Clinical Medical Ethics to focus on health disparities

The 22nd annual conference of The MacLean Center for Clinical Medical Ethics at the University of Chicago will be held at the University of Chicago Law School, 1111 E. 60th Street, on Fri., Nov. 12, from 1 to 5 pm, and Sat., Nov. 13, from 7:30 am to 5:15 pm.

10 Nov 2010

Low levels of growth hormone may contribute to growth defects in cystic fibrosis

A new study using a pig model of cystic fibrosis (CF) suggests that low levels of a growth promoting hormone at or before birth may contribute to growth defects in patients with CF.

10 Nov 2010

Cerus prices underwritten public offering

Cerus Corporation today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million.

10 Nov 2010

Repros third quarter net loss decreases to $1.2 million

Repros Therapeutics Inc. today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.

10 Nov 2010

First Edition: November 10, 2010

Today's headlines include new survey results regarding employers' and the insurance coverage they provide to employees, as well as more details on health insurance open season.

10 Nov 2010

Women taking HPV vaccine need only two HPV screening tests for rest of their lives: Research

Women who have had the human papillomavirus vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool.

10 Nov 2010

Fibroblast growth factor-2 stimulates periodontal regeneration: Study

It is well known that oral infection progressively destroys periodontal tissues and is the leading cause of tooth loss in adults. A major goal of periodontal treatment is regeneration of the tissues lost to periodontitis. Unfortunately, most current therapies cannot predictably promote repair of tooth-supporting defects. A variety of regenerative approaches have been used clinically using bone grafts and guiding tissue membranes with limited success.

10 Nov 2010

Nine research projects awarded access to PRACE Research Infrastructure

Nine research projects, two from Germany, two from Spain and one each from France, Hungary, the Netherlands, Portugal and the UK, have been awarded access to the PRACE Research Infrastructure. In total 362.8 Million compute core hours were granted for the JUGENE, IBM BlueGene/P, hosted by the Gauss-Centre for Supercomputing member site in Jülich, Germany, which is the first Petascale HPC system available to researchers through PRACE.

10 Nov 2010

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.

10 Nov 2010

Myrexis presents key preclinical findings of MPI-0485520 at ACR/ARHP meeting

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented key preclinical findings of the Company's novel oral anti-interferon, MPI-0485520, at the 74th Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in Atlanta, Georgia.

10 Nov 2010

Researchers study drug's ability to restore retinal health in eyes of diabetic patients

One drug's startling ability to restore retinal health in the eyes of diabetic mice has researchers wanting to learn more about how it works and whether it might do the same for people.

10 Nov 2010

Supreme Court rejects early request to review health overhaul

"The U.S. Supreme Court on Monday rejected a long-shot request for a review of the Obama administration's health-care overhaul before the matter has been fully litigated. The high court's rejection of the health-care challenge, brought by a conservative legal group in California, wasn't a surprise. …The high court almost never hears cases before they have been fully litigated in the lower courts, and it hadn't asked the Obama administration to file legal papers responding to the appeal."

10 Nov 2010

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

As obesity rates and the cost of healthcare continue to be on the rise, the 2010 mHealth Summit in Washington D.C. is bringing together industry thought leaders, researchers, and policy makers to discuss the opportunities to address pressing public health issues utilizing mobile health technology.

10 Nov 2010

U.S. Preventive Services Task Force expected to announce open positions shortly

The agency that oversees the U.S. Preventive Services Task Force is likely to announce soon that it will accept nominations for open positions until Nov. 29.

10 Nov 2010

Medicinal mushroom formula fights breast cancer

Researchers at Indiana University and Methodist Research Institute studied an innovative medicinal mushroom formula against breast cancer. The impressive results are found in the December issue of the International Journal of Oncology. Lead investigator Dr. Daniel Sliva says, "The formula inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells."

10 Nov 2010

Research News and Research

Study finds different DNA alterations in tumor genomes of smokers and never-smokers

Study finds no association between working in wafer fabrication cleanrooms, cancer mortality

Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral

Data from AVEO's tivozanib-FOLFOX6 combination Phase 1b trial presented at 22nd EORTC-NCI-AACR

EuroNanoMed funds 8 projects with €8 Million for transnational research projects in nanomedicine

Conference of The MacLean Center for Clinical Medical Ethics to focus on health disparities

Low levels of growth hormone may contribute to growth defects in cystic fibrosis

Cerus prices underwritten public offering

Repros third quarter net loss decreases to $1.2 million

First Edition: November 10, 2010

Women taking HPV vaccine need only two HPV screening tests for rest of their lives: Research

Fibroblast growth factor-2 stimulates periodontal regeneration: Study

Nine research projects awarded access to PRACE Research Infrastructure

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Myrexis presents key preclinical findings of MPI-0485520 at ACR/ARHP meeting

Researchers study drug's ability to restore retinal health in eyes of diabetic patients

Supreme Court rejects early request to review health overhaul

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

U.S. Preventive Services Task Force expected to announce open positions shortly

Medicinal mushroom formula fights breast cancer

Spectroscopy Applications in the Environment eBook eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News